Gene · 406902
Papers3,238
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
601 to 620 of 3,238
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Impact of the Exposome on the Epigenome in Inflammatory Bowel Disease Patients and Animal Models. | Int J Mol Sci | 2022 | 35886959 | PubTator, text mining | PubMed |
| Further Insights on RNA Expression and Sperm Motility. | Genes (Basel) | 2022 | 35886074 | PubTator, text mining | PubMed |
| A Possible Cause for the Differential Expression of a Subset of miRNAs in Mesenchymal Stem Cells Derived from Myometrium and Leiomyoma. | Genes (Basel) | 2022 | 35885889 | PubTator, text mining | PubMed |
| Extracellular Vesicles-ceRNAs as Ovarian Cancer Biomarkers: Looking into circRNA-miRNA-mRNA Code. | Cancers (Basel) | 2022 | 35884464 | PubTator, text mining | PubMed |
| The Significance of MicroRNAs in the Molecular Pathology of Brain Metastases. | Cancers (Basel) | 2022 | 35884446 | PubTator, text mining | PubMed |
| Exosomes in Alpha-Synucleinopathies: Propagators of Pathology or Potential Candidates for Nanotherapeutics? | Biomolecules | 2022 | 35883513 | PubTator, text mining | PubMed |
| MicroRNA expression profiling of endocrine sensitive and resistant breast cancer cell lines. | Biochem Biophys Rep | 2022 | 35879960 | PubTator, text mining | PubMed |
| Computational method using heterogeneous graph convolutional network model combined with reinforcement layer for MiRNA-disease association prediction. | BMC Bioinformatics | 2022 | 35879658 | PubTator, text mining | PubMed |
RNA Sequencing Reveals the Expression Profiles of circRNAs and Indicates Hsa_circ_0070562 as a Pro-osteogenic Factor in Bone Marrow-Derived Mesenchymal Stem Cells of Patients With Ankylosing Spondylitis. | Front Genet | 2022 | 35873481 | PubTator, text mining | PubMed |
| Circulating microRNAs in cellular and antibody-mediated heart transplant rejection. | J Heart Lung Transplant | 2022 | 35872109 | PubTator, text mining | PubMed |
| Role of extracellular vesicles in lung diseases. | Chin Med J (Engl) | 2022 | 35866573 | PubTator, text mining | PubMed |
| Exosomes from bone marrow mesenchymal stem cells decrease chemosensitivity of acute myeloid leukemia cells via delivering miR-10a. | Biochem Biophys Res Commun | 2022 | 35863089 | PubTator, text mining | PubMed |
| Muscone improves hypoxia/reoxygenation (H/R)-induced neuronal injury by blocking HMGB1/TLR4/NF-κB pathway via modulating microRNA-142. | PeerJ | 2022 | 35860039 | PubTator, text mining | PubMed |
| Polysaccharides Extracted from Angelica sinensis (Oliv.) Diels Relieve the Malignant Characteristics of Glioma Cells through Regulating the MiR-373-3p-Mediated TGF-β/Smad4 Signaling Pathway. | Evid Based Complement Alternat Med | 2022 | 35855826 | PubTator, text mining | PubMed |
| Serum RNA biomarkers for predicting survival in non-human primates following thoracic radiation. | Sci Rep | 2022 | 35853961 | PubTator, text mining | PubMed |
| Pathogenic Role of MicroRNA Dysregulation in Podocytopathies. | Front Physiol | 2022 | 35845986 | PubTator, text mining | PubMed |
| Evaluation Value of Serum miR-4299 and miR-16-5p in Risk Stratification of Sepsis-Induced Acute Kidney Injury. | Biomed Res Int | 2022 | 35845963 | PubTator, text mining | PubMed |
| CircFAT1 Promotes Lung Adenocarcinoma Progression by Sequestering miR-7 from Repressing IRS2-ERK-mediated CCND1 Expression. | Int J Biol Sci | 2022 | 35844799 | PubTator, text mining | PubMed |
| Editorial: Understanding the RNA Species in the Extracellular Vesicles of Multiple Myeloma. | Front Oncol | 2022 | 35814373 | PubTator, text mining | PubMed |
| The Effect of Hypoxia-Induced Exosomes on Anti-Tumor Immunity and Its Implication for Immunotherapy. | Front Immunol | 2022 | 35812406 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406902/papers?page=31